A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Clinical trial NCT03739840 · TERMINATED

Trial details

NCT number: NCT03739840
Sponsor: UCB Biopharma SRL
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Drug-Resistant Epilepsy Focal-Onset Seizures

Start date: 2019-03-06
Primary completion: 2020-09-28
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.